Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio.

Autor: Lu Q; Foshan Fosun Chancheng Hospital, P.R. China.; Junxin Precision Oncology Group, P.R. China., Yan W; Baptist Health System, Lexington, KY, United States.; Junxin Precision Oncology Group, P.R. China., Zhu A; Mayo Clinic Alix School of Medicine, Scottsdale, AZ, United States., Tubin S; Albert Einstein Collage of Medicine New York, Center for Ion Therapy, Medaustron, Austria., Mourad WF; Department of Radiation Medicine Markey Cancer Center, University of Kentucky - College of Medicine, United States., Yang J; Foshan Fosun Chancheng Hospital, P.R. China.; Junxin Precision Oncology Group, P.R. China.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2023 Oct 20; Vol. 44, pp. 100691. Date of Electronic Publication: 2023 Oct 20 (Print Publication: 2024).

Evaluating the clinical acceptability of deep learning contours of prostate and organs-at-risk in an automated prostate treatment planning process.

Autor: Duan J; Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, USA., Bernard M; Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, USA., Downes L; Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, USA., Willows B; Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, USA., Feng X; Carina Medical LLC, Lexington, Kentucky, USA., Mourad WF; Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, USA., St Clair W; Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, USA., Chen Q; Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, USA.

Publikováno v: Medical physics [Med Phys] 2022 Apr; Vol. 49 (4), pp. 2570-2581. Date of Electronic Publication: 2022 Feb 21.

The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches.

Autor: Tubin S; MedAustron Center for Ion Therapy and Research, Marie Curie Strasse 5, A-2700 Wiener Neustadt, Austria., Yan W; Department of Radiation Oncology, Thomas Jefferson University, 11th St, Philadelphia, PA 19107, USA., Mourad WF; Department of Radiation Medicine, Markey Cancer Center, University of Kentucky, Medical Center, MN 150 - Lexington, KY 40536-0298, USA., Fossati P; MedAustron Center for Ion Therapy and Research, Marie Curie Strasse 5, A-2700 Wiener Neustadt, Austria., Khan MK; Department of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute, 1365-C Clifton Road, Atlanta, GA 30322, USA.

Publikováno v: Future oncology (London, England) [Future Oncol] 2020 Jun; Vol. 16 (16), pp. 1137-1151. Date of Electronic Publication: 2020 Apr 27.

Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment.

Autor: Tubin S; KABEG Klinikum Klagenfurt, Institute of Radiation Oncology, Feschnigstraße 11, 9020, Klagenfurt am Wörthersee, Austria. slavisa.tubin@kabeg.at., Khan MK; Department of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute, 1365-C Clifton Road, 30322, Atlanta, NE, Georgia., Salerno G; Department of Neurosciences, Mental Health and Sensory Organs / Department of Clinical and Molecular Medicine, Universita' La Sapienza Roma, Ospedale Sant' Andrea, Via di Grottarossa, 1035, 00189, Rome, RM, Italy., Mourad WF; Markey Cancer Center, Department of Radiation Medicine, University of Kentucky Lexington ky, UK Medical Center MN 150, Lexington, KY, 40536-0298, USA., Yan W; Department of Radiation Oncology, Thomas Jefferson University, 111 S 11th St, Philadelphia, PA, 19107, USA., Jeremic B; BioIRC, R&D Center for Biomedical Research, Kragujevac, SERBIA and Research Institute of Clinical Medicine, 13 Tevdore Mgvdeli St, 0112, Tbilisi, Georgia.

Publikováno v: Radiation oncology (London, England) [Radiat Oncol] 2019 Nov 26; Vol. 14 (1), pp. 212. Date of Electronic Publication: 2019 Nov 26.

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation.

Autor: Buchwald ZS; Department of Radiation Oncology, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory University, Atlanta, GA, United States., Wynne J; Department of Radiation Oncology, Emory University, Atlanta, GA, United States., Nasti TH; Department of Microbiology and Immunology, Emory University, Atlanta, GA, United States., Zhu S; Department of Radiation Oncology, Henry Ford Health System, Detroit, MI, United States., Mourad WF; Erlanger UT Radiation Oncology, Chattanooga, TN, United States., Yan W; Mitchell Cancer Institute, University of Southern Alabama, Mobile, AL, United States., Gupta S; Georgia Cancer Center, Augusta University, Augusta, GA, United States., Khleif SN; Georgia Cancer Center, Augusta University, Augusta, GA, United States., Khan MK; Department of Radiation Oncology, Emory University, Atlanta, GA, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2018 Dec 13; Vol. 8, pp. 612. Date of Electronic Publication: 2018 Dec 13 (Print Publication: 2018).